Digestive Diseases and Sciences

, Volume 57, Issue 1, pp 196–203 | Cite as

The Relationship Between Arterial Stiffness and Nonalcoholic Fatty Liver Disease

  • Yong-Jae Lee
  • Jae-Yong Shim
  • Byung-Soo Moon
  • Youn-Ho Shin
  • Dong-Hyuk Jung
  • Jung-Hyun Lee
  • Hye-Ree Lee
Original Article



Nonalcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease and some studies have documented its link with cardiovascular risk factors. This study aimed to investigate the association between arterial stiffness and NAFLD.


Among 1,442 health check-up subjects (955 men, 487 women), we examined the association between brachial-ankle pulse wave velocity (baPWV) as a measurement of arterial stiffness and the presence of NAFLD based on abdominal sonographic findings. Multivariate linear and logistic regression analyses were conducted to examine the independent association between baPWV and the presence of NAFLD in gender-specific manners.


In multivariate regression analysis, NAFLD was found to be independently associated with baPWV in both men and women. Moreover, in multivariate logistic regression analysis, a graded independent relation was found between higher levels of baPWV and the prevalence risk of NAFLD. Odds ratios (95% CI) for the highest vs. the lowest quartile of baPWV were 1.85 (range, 1.13–2.62) in men and 3.32 (1.45–7.62) in women after adjusting for age, smoking status, regular exercise, body mass index, blood pressure, fasting plasma glucose, triglyceride, HDL-cholesterol, hypertension and diabetes.


Arterial stiffness was independently associated with the prevalence risk for NAFLD regardless of classical CVD risk factors.


Arterial stiffness Pulse wave velocity Nonalcoholic fatty liver disease Cardiovascular disease Inflammation 



Nonalcoholic fatty liver disease


Cardiovascular disease


Brachial-ankle pulse wave velocity


White blood cell


Coefficients of variations


Homeostasis model assessment of the insulin resistance index


Intima-media thickness


Reactive oxygen species




Tumor necrosis factor-α


Nitric oxide


Plasminogen activator inhibitor-1



The authors would like to thank Mr. Tim Gitzen for his help in editing the manuscript.

Conflict of interest

No competing financial interests exist.


  1. 1.
    Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883–889.PubMedCrossRefGoogle Scholar
  2. 2.
    Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419.PubMedCrossRefGoogle Scholar
  3. 3.
    Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850.PubMedCrossRefGoogle Scholar
  4. 4.
    Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341–1350.PubMedCrossRefGoogle Scholar
  5. 5.
    Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–873.PubMedCrossRefGoogle Scholar
  6. 6.
    Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vascular Biol. 2003;23:554–566.CrossRefGoogle Scholar
  7. 7.
    van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke. 2001;32:454–460.PubMedCrossRefGoogle Scholar
  8. 8.
    Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26:615–622.PubMedCrossRefGoogle Scholar
  9. 9.
    Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15.PubMedCrossRefGoogle Scholar
  10. 10.
    Kim YJ, Kim YJ, Cho BM, Lee S. Metabolic syndrome and arterial pulse wave velocity. Acta Cardiol. 2010;65:315–321.PubMedCrossRefGoogle Scholar
  11. 11.
    Tanaka H, Munakata M, Kawano Y, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022–2027.PubMedCrossRefGoogle Scholar
  12. 12.
    Seo SK, Cho S, Kim HY, et al. Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women. Menopause. 2009;16:937–943.PubMedCrossRefGoogle Scholar
  13. 13.
    Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J. 1986;292:13–15.CrossRefGoogle Scholar
  14. 14.
    Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750.PubMedCrossRefGoogle Scholar
  15. 15.
    Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005;42:473–480.PubMedCrossRefGoogle Scholar
  16. 16.
    Salvi P, Ruffini R, Agnoletti D, et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens. 2010;28:1699–1707.PubMedCrossRefGoogle Scholar
  17. 17.
    Vlachopoulos C, Manesis E, Baou K, et al. Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study. Am J Hypertens. 2010;23:1183–1189.PubMedCrossRefGoogle Scholar
  18. 18.
    Park SH, Kim BI, Yun JW, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004;19:694–698.PubMedCrossRefGoogle Scholar
  19. 19.
    Wang CC, Lin SK, Tseng YF, et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24:1411–1416.PubMedCrossRefGoogle Scholar
  20. 20.
    Kogiso T, Moriyoshi Y, Shimizu S, Nagahara H, Shiratori K. High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike information criterion scoring system in the general Japanese population. J Gastroenterol. 2009;44:313–321.PubMedCrossRefGoogle Scholar
  21. 21.
    Wieckowska A, Papouchado BG, Li Z, et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:1372–1379.PubMedCrossRefGoogle Scholar
  22. 22.
    Bahcecioglu IH, Yalniz M, Ataseven H, et al. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients in nonalcoholic steatohepatitis. Heaptogastroenterology. 2005;52:1549–1553.Google Scholar
  23. 23.
    Lee YJ, Lee HR, Shim JY, Moon BS, Lee JH, Kim JK. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:888–894.PubMedCrossRefGoogle Scholar
  24. 24.
    Bhagat K, Vallance P. Effect of cytokines on nitric oxide pathways in human vasculature. Curr Opin Nephrol Hypertens. 1999;8:89–96.PubMedCrossRefGoogle Scholar
  25. 25.
    Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol. 1997;15:163–167.PubMedGoogle Scholar
  26. 26.
    Bataller R, Sancho-Bru P, Ginès P, et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology. 2003;125:117–125.PubMedCrossRefGoogle Scholar
  27. 27.
    Sookoian S, Castaño GO, Burgueño AL, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis. 2009;209:585–591.PubMedCrossRefGoogle Scholar
  28. 28.
    Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007;30:2119–2121.PubMedCrossRefGoogle Scholar
  29. 29.
    Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol. 2008;103:2263–2271.PubMedCrossRefGoogle Scholar
  30. 30.
    Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121.PubMedCrossRefGoogle Scholar
  31. 31.
    Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52.PubMedCrossRefGoogle Scholar
  32. 32.
    Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006;26:856–863.PubMedCrossRefGoogle Scholar
  33. 33.
    Jimba S, Nakagami T, Takahashi M, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005;22:1141–1145.PubMedCrossRefGoogle Scholar
  34. 34.
    Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J. 1986;292:13–15.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Yong-Jae Lee
    • 1
  • Jae-Yong Shim
    • 1
  • Byung-Soo Moon
    • 2
  • Youn-Ho Shin
    • 3
  • Dong-Hyuk Jung
    • 1
  • Jung-Hyun Lee
    • 4
  • Hye-Ree Lee
    • 1
  1. 1.Department of Family MedicineYonsei University College of MedicineSeoulKorea
  2. 2.Department of Internal MedicineYonsei University College of MedicineSeoulKorea
  3. 3.Department of PediatricsCHA University College of MedicineSeoulKorea
  4. 4.Department of Health Promotion CenterGangnam Severance Hospital, Yonsei University College of MedicineSeoulKorea

Personalised recommendations